aluminum sulfate has been researched along with Malaria, Vivax in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnwell, JW; Bounngaseng, A; Collins, WE; Long, CA; McClure, H; Nace, D; Roberts, J; Saul, A; Strobert, E; Sullivan, JS; Williams, T | 1 |
| Collins, WE; Kaslow, DC; Lal, AA; Sullivan, JS; Xiao, L; Yang, C | 1 |
2 other study(ies) available for aluminum sulfate and Malaria, Vivax
| Article | Year |
|---|---|
Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzees.
Topics: Alum Compounds; Animals; Anopheles; Antigens, Protozoan; Antigens, Surface; Female; Germ Cells; Macaca mulatta; Malaria Vaccines; Malaria, Vivax; Male; Mannitol; Oils; Oleic Acids; Plasmodium vivax; Vaccines, Combined | 2006 |
Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Protozoan; Female; Immunoglobulin G; Lymphocyte Activation; Malaria Vaccines; Malaria, Vivax; Male; Merozoite Surface Protein 1; Parasitemia; Peptide Fragments; Plasmodium vivax; Polymers; Saimiri; Spleen; T-Lymphocytes; Vaccines, Synthetic | 1999 |